Successful visual recovery.

The 12th, in three bullous keratopathy patients with corneal endothelium to keep the transparent cornea of the eye pain, vision is reduced, team Doshisha University and Kyotofuritsuidai, Shiga Medical University transplant corneal endothelial cells were prepared by culturing it has announced that it conducted clinical studies, to its success in visual recovery. According to the team, transplantation of corneal endothelial cells in culture is a world first.
Currently, there are treatments that were implanted with corneal endothelium taken from the cornea, or replaced with areas that are bad, or to transplant the cornea itself, the provider of the cornea is a chronic shortage. Furthermore, since the corneal endothelial cells does not increase in the human body was also reduced to be implanted.
There is an advantage to be able to or implanted in many patients or transplanted back into the same patient the method of this. Please complete the further research in order to regain the light of many people by advancing as soon as possible to establish a method of treatment by taking advantage.



京都府立医大や同志社大、滋賀医大のチームは１２日、目の角膜を透明に保つ角膜内皮が傷み、視力が低下する水疱性角膜症患者３人に、培養して作った角膜内皮細胞を移植する臨床研究を実施し、視力回復に成功したと発表した。チームによると、培養した角膜内皮細胞の移植は世界初。
　現在、角膜から採取した角膜内皮を移植し、悪くなった部分と取り換えたり、角膜そのものを移植したりする治療法があるが、慢性的に角膜の提供者が不足。さらに、角膜内皮細胞は人の体内で増えないため、移植しても減ることもあった。
　今回の手法は多くの患者に移植したり、同じ患者に再度移植したりできる利点がある。利点を生かして治療方法の確立を早急に進めて多くの方々の光を取り戻すために更なる研究を進めてください。